Creating health warning labels for e-cigarettes
Developing and testing health warning labels on the ENDS device
This study is looking at how pictures on warning labels for e-cigarettes can help young people understand the risks of using them and encourage them to think about quitting.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida International University NIH-funded |
| Lab location | 1 site (Miami, United States) |
| Project ID | NIH-11079506 on NIH RePORTER |
What this research studies
This research focuses on developing and testing health warning labels for electronic nicotine delivery systems (ENDS), commonly known as e-cigarettes, which are increasingly used by young people. The study aims to address the widespread misperceptions about the safety of these devices by creating pictorial health warning labels that communicate the risks associated with their use. Through a systematic approach, the research will evaluate how these labels affect young users' perceptions, satisfaction, and intentions to quit, using both subjective surveys and objective measures like nicotine levels in the blood. The research will involve literature reviews, expert consultations, and focus groups to refine the warning messages and assess their effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 21 to 29 who currently use e-cigarettes.
Not a fit: Patients who do not use e-cigarettes or are older than 29 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective health communication strategies that reduce e-cigarette use among young people and help prevent nicotine dependence.
How similar studies have performed: Previous research has shown that health warning labels can influence smoking behaviors, suggesting that this approach may be effective for e-cigarettes as well.
Where this research is happening
Miami, United States
- Florida International University — Miami, United States (Active)
Researchers
- Principal investigator: Maziak, Wasim — Florida International University
- Study coordinator: Maziak, Wasim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.